{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:50:07Z","timestamp":1781859007396,"version":"3.54.5"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.0951","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:01:53Z","timestamp":1646413313000},"page":"e220951","source":"Crossref","is-referenced-by-count":26,"title":["Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily"],"prefix":"10.1001","volume":"5","author":[{"given":"Andrea","family":"King","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Vena","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingcai","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"10","key":"zoi220053r1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000.","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"zoi220053r4","first-page":"189","article-title":"Attributable risk for oral cancer in northern Italy.","volume":"2","author":"Negri","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"zoi220053r5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/jnci\/93.11.824","article-title":"Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.","volume":"93","author":"Howe","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"zoi220053r6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","article-title":"Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.","volume":"42","author":"Marrero","year":"2005","journal-title":"J Hepatol"},{"key":"zoi220053r7","author":"Mukamal","year":"2006"},{"key":"zoi220053r8","author":"Ebbert","year":"2005"},{"issue":"8","key":"zoi220053r9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III.","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi220053r10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0376-8716(99)00130-1","article-title":"Drinking as a risk factor for sustained smoking.","volume":"59","author":"Dawson","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi220053r11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.15288\/jsad.2020.81.426","article-title":"Searching for personalized medicine for binge drinking smokers: smoking cessation using varenicline, nicotine patch, or combination nicotine replacement therapy.","volume":"81","author":"Kaye","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"zoi220053r12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an a4\u00df2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"zoi220053r13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an a4\u00df2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"zoi220053r14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fnins.2014.00426","article-title":"Nicotinic receptor modulation to treat alcohol and drug dependence.","volume":"8","author":"Rahman","year":"2015","journal-title":"Front Neurosci"},{"issue":"8","key":"zoi220053r15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.biopsych.2012.09.019","article-title":"Nicotinic acetylcholine receptors containing the a4 subunit modulate alcohol reward.","volume":"73","author":"Liu","year":"2013","journal-title":"Biol Psychiatry"},{"key":"zoi220053r16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fpsyt.2013.00029","article-title":"Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.","volume":"4","author":"Hendrickson","year":"2013","journal-title":"Front Psychiatry"},{"issue":"2","key":"zoi220053r17","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12924","article-title":"The impact of varenicline on alcohol consumption in subjects with alcohol use disorders: systematic review and meta-analyses.","volume":"81","author":"Gandhi","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"zoi220053r18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/acer.2012.36.issue-5","article-title":"Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.","volume":"36","author":"Childs","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"zoi220053r19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers.","volume":"66","author":"McKee","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"3","key":"zoi220053r20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/jsc.2020.13","article-title":"An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study.","volume":"15","author":"Fucito","year":"2020","journal-title":"J Smok Cessat"},{"issue":"3","key":"zoi220053r21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers.","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"zoi220053r22","author":"Epstein","year":"2007"},{"issue":"7","key":"zoi220053r23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/ntr\/ntq083","article-title":"Alcohol use and initial smoking lapses among heavy drinkers in smoking cessation treatment.","volume":"12","author":"Kahler","year":"2010","journal-title":"Nicotine Tob Res"},{"issue":"24","key":"zoi220053r24","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1007\/s00213-014-3613-3","article-title":"Acute effects of low and high dose alcohol on smoking lapse behavior in a laboratory analogue task.","volume":"231","author":"Kahler","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"zoi220053r25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2017.11.017","article-title":"Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: a randomized controlled trial.","volume":"184","author":"Hurt","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi220053r26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","article-title":"Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: a randomized clinical trial.","volume":"75","author":"O\u2019Malley","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi220053r27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/JCP.0000000000001172","article-title":"Safety and efficacy of varenicline for smoking cessation in alcohol-dependent smokers in concurrent treatment for alcohol use disorder: a pilot, randomized placebo-controlled trial.","volume":"40","author":"Zawertailo","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"zoi220053r28","author":"Ray","year":"2021"},{"key":"zoi220053r29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1741-7015-11-140","article-title":"Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? a randomised controlled trial.","volume":"11","author":"Hajek","year":"2013","journal-title":"BMC Med"},{"issue":"2","key":"zoi220053r30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jama.2014.7195","article-title":"Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.","volume":"312","author":"Koegelenberg","year":"2014","journal-title":"JAMA"},{"key":"zoi220053r31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-014-0172-8","article-title":"Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.","volume":"12","author":"Ramon","year":"2014","journal-title":"BMC Med"},{"key":"zoi220053r32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"zoi220053r34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ntr\/ntr137","article-title":"Determinants of tobacco use and renaming the FTND to the Fagerstr\u00f6m Test for Cigarette Dependence.","volume":"14","author":"Fagerstr\u00f6m","year":"2012","journal-title":"Nicotine Tob Res"},{"issue":"12","key":"zoi220053r37","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"11","key":"zoi220053r39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/add.1989.84.issue-11","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"zoi220053r40","doi-asserted-by":"publisher","first-page":"S620","DOI":"10.2105\/AJPH.2014.302097","article-title":"Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort.","volume":"104","author":"Asvat","year":"2014","journal-title":"Am J Public Health"},{"key":"zoi220053r41","author":"Ebbert","year":"2015"},{"issue":"1","key":"zoi220053r42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32053","article-title":"Assessment of racial differences in pharmacotherapy efficacy for smoking cessation: secondary analysis of the EAGLES randomized clinical trial.","volume":"4","author":"Nollen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi220053r43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations.","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"zoi220053r44"},{"key":"zoi220053r45","author":"Plebani","year":"2013"},{"key":"zoi220053r46","author":"McKee","year":"2008"},{"issue":"10","key":"zoi220053r47","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/npp.2015.80","article-title":"Nicotinic mechanisms modulate ethanol withdrawal and modify time course and symptoms severity of simultaneous withdrawal from alcohol and nicotine.","volume":"40","author":"Perez","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"zoi220053r49","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.","volume":"39","author":"De Bejczy","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"zoi220053r50","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/JCP.0000000000001056","article-title":"Efficacy of varenicline in patients with severe alcohol dependence: a pilot double-blind randomized and controlled study.","volume":"39","author":"Pfeifer","year":"2019","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"zoi220053r51","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00213-018-4921-9","article-title":"The contribution of agonist and antagonist activities of a4\u00df2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.","volume":"235","author":"Rollema","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"zoi220053r52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25651","article-title":"Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.","volume":"6","author":"Govind","year":"2017","journal-title":"Elife"},{"issue":"6","key":"zoi220053r53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2165\/11536100-000000000-00000","article-title":"Combination pharmacotherapy for stopping smoking: what advantages does it offer?","volume":"70","author":"Ebbert","year":"2010","journal-title":"Drugs"},{"issue":"8","key":"zoi220053r54","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.bcp.2013.07.007","article-title":"Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.","volume":"86","author":"Doyon","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"zoi220053r55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108100","article-title":"Making lemonade from SARS coronavirus\u20132 lemons: transitioning a smoking cessation trial to a virtual platform.","volume":"117","author":"Mahoney","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"zoi220053r33","volume-title":"Helping Patients Who Drink Too Much: A Clinician\u2019s Guide","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2005"},{"key":"zoi220053r35","author":"Babor","year":"2001"},{"key":"zoi220053r36","volume-title":"User\u2019s Guide for the Structured Clinical Interview for DSM-5 Disorders, Research Version (SCID-5-RV).","author":"First","year":"2015"},{"key":"zoi220053r38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption","author":"Sobell","year":"1992"},{"key":"zoi220053r2","unstructured":"Centers for Disease Control and Prevention. Smoking & tobacco use: fast facts. 2021. Accessed March 31, 2021. https:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/fast_facts\/index.htm#beginning"},{"key":"zoi220053r3","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Alcohol facts and statistics. National Institutes of Health; June 2021. Accessed July 16, 2021. https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/alcohol-facts-and-statistics"},{"key":"zoi220053r48","unstructured":"US Food and Drug Administration. FDA drug safety communication: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking. Updated February 26, 2018. Accessed February 2, 2022. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-label-stop-smoking-drug-chantix-varenicline-include"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2789620\/king_2022_oi_220053_1645727152.34713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:02:07Z","timestamp":1646413327000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2789620"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0951","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]}}}